Clinical Trials on Trastorno de aprendizaje específico
Total 0 results
Nothing found
Sponsors and Collaborators
- Honda R and D Americas, Inc.
- Zahra Rabbani Khah
- Marilia Medicine School
- Health Parametrics Inc.
- Jeffrey W. Clark, MD
- Ionis Pharmaceuticals
- New York State Health Foundation
- CTC Bio, Inc.
- MingSight Pharmaceuticals Pty Limited
- Rex Bionics Plc
- European Network For Smoking and Tobacco Prevention
- Medtronic Atrial Fibrillation Solutions
- Montreal Neurological Institute and Hospital
- Mitchell Scheiman
- Jeffrey Rudolph
- John Granton
- Kawin Technology Share-holding Co., Ltd.
- The Third Hospital of Changsha
- Wushan County People's Hospital
- Northern California Melanoma Center
- View Full List
Medical Conditions
- Ascaris Suum
- Locally Advanced NSCLC
- Pancreatic Neoplasms
- Liver Hemangioma
- Pregnancy-Related Condition, Unspecified
- Fasting, Diet, Chemotherapy, Toxicity
- Waldenstrom's Macroglobulinemia Recurrent
- H.Pylori Infection
- ACTH-Secreting Pituitary Adenoma
- HDT-AHCT
- Brain MRI
- LSIL
- Renal Cancer Metastatic
- Primary Generalized Dystonia
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Metastatic Spine Lesions
- Hyperthyroidism, Autoimmune
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Periferal Arterial Occlusive Disease, PAOD
- Advanced Esophageal Cancers
- View Full List
Drug Interventions
- Postoperative analgesia management
- ESK981
- Hydroxychloroquine
- CKD-519
- Levobupivacaine, clonidine
- Ombrabulin (AVE8062)
- Levcromakalim
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Nimotuzumab
- Bendamustine
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Pentostatin
- Rifaximin
- Fludarabine
- AZD7798
- 200 µg doxorubicin-containing MNA
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Belarus
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Finland
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Italy
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Moldova
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Peru
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in South Africa
- CRO list by country